{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T12:27:48Z","timestamp":1765024068415,"version":"3.46.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jbo.2025.100730","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:44:51Z","timestamp":1763772291000},"page":"100730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Chronic kidney disease and denosumab in metastatic bone disease: A multicenter Turkish cohort study on severe hypocalcemia, skeletal events, and survival"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9593-0942","authenticated-orcid":false,"given":"Halil \u0130brahim","family":"Ellez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00fcseyin Salih","family":"Semiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferhat","family":"Ekinci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atike P\u0131nar","family":"Erdo\u011fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Ku\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Karata\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ertu\u011frul","family":"Bayram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kubilay","family":"Karaboyun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Havva Ye\u015fil","family":"\u00c7\u0131nk\u0131r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilg\u00fcn","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melek Karakurt","family":"Ery\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esma T\u00fcrkmen","family":"Bekmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zkan","family":"Alan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melike","family":"\u00d6z\u00e7elik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yakup","family":"D\u00fczk\u00f6pr\u00fc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teoman","family":"\u015eakalar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naziye","family":"Ak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuf","family":"\u0130lhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tu\u011fba","family":"Yavuz\u015fen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naz\u0131m Serdar","family":"Turhal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbo.2025.100730_b0005","doi-asserted-by":"crossref","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: Causes, consequences and therapeutic opportunities","volume":"Vol. 2","author":"Mundy","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.jbo.2025.100730_b0010","doi-asserted-by":"crossref","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: Clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jbo.2025.100730_b0015","doi-asserted-by":"crossref","DOI":"10.1038\/sj.cr.7290266","article-title":"Mechanisms of cancer metastasis to the bone","volume":"Vol. 15","author":"Yin","year":"2005","journal-title":"Cell Res."},{"key":"10.1016\/j.jbo.2025.100730_b0020","article-title":"Current comprehensive understanding of denosumab (the RANKL neutralizing antibody) in the treatment of bone metastasis of malignant tumors, including pharmacological mechanism and clinical trials","volume":"Vol. 13","author":"Lu","year":"2023","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.jbo.2025.100730_b0025","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfaa359","article-title":"Hypocalcemia and bone mineral changes in hemodialysis patients with low bone mass treated with denosumab: A 2-year observational study","volume":"36","author":"Hiramatsu","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.jbo.2025.100730_b0030","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa851","article-title":"Denosumab safety and efficacy among participants in the FREEDOM extension study with mild to moderate chronic kidney disease","volume":"106","author":"Broadwell","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.jbo.2025.100730_b0035","article-title":"Management of skeletal-related events in patients with advanced prostate cancer and bone metastases: Incorporating new agents into clinical practice","volume":"6","author":"So","year":"2012","journal-title":"J. Canad. Urol. Assoc."},{"issue":"8","key":"10.1016\/j.jbo.2025.100730_b0040","article-title":"Bisphosphonates versus denosumab for prevention of pathological fracture in advanced cancers with bone metastasis: A meta-analysis of randomized controlled trials","volume":"4","author":"Al Farii","year":"2020","journal-title":"J Am Acad Orthop Surg Glob Res Rev."},{"issue":"1","key":"10.1016\/j.jbo.2025.100730_b0045","article-title":"A 5-year retrospective cohort study of denosumab induced medication related osteonecrosis of the jaw in osteoporosis patients","volume":"12","author":"Jung","year":"2022","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.jbo.2025.100730_b0050","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.1613","article-title":"A single-dose study of denosumab in patients with various degrees of renal impairment","volume":"27","author":"Block","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.jbo.2025.100730_b0055","doi-asserted-by":"crossref","DOI":"10.1007\/s00223-020-00754-8","article-title":"A simple-to-use score for identifying individuals at high risk of denosumab-associated hypocalcemia in postmenopausal osteoporosis: A real-world cohort study","volume":"107","author":"Kim","year":"2020","journal-title":"Calcif. Tissue Int."},{"issue":"12","key":"10.1016\/j.jbo.2025.100730_b0060","article-title":"Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: A 15-year study in two large US health systems","volume":"21","author":"Oster","year":"2013","journal-title":"Support. Care Cancer"},{"issue":"2","key":"10.1016\/j.jbo.2025.100730_b0065","doi-asserted-by":"crossref","DOI":"10.1038\/pcan.2011.7","article-title":"Mortality following bone metastasis and skeletal-related events among men with prostate cancer: A population-based analysis of US Medicare beneficiaries, 1999-2006","volume":"14","author":"Sathiakumar","year":"2011","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"1","key":"10.1016\/j.jbo.2025.100730_b0070","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-011-1721-x","article-title":"Mortality following bone metastasis and skeletal-related events among women with breast cancer: A population-based analysis of U.S. Medicare beneficiaries, 1999-2006","volume":"131","author":"Sathiakumar","year":"2012","journal-title":"Breast Cancer Res Treat."},{"issue":"1","key":"10.1016\/j.jbo.2025.100730_b0075","doi-asserted-by":"crossref","DOI":"10.1136\/jim-2016-000178","article-title":"Can lumbar spine bone mineral density predict readmission in denosumab-Treated patients with chronic kidney disease?","volume":"65","author":"Cheng","year":"2017","journal-title":"J. Invest. Med."},{"issue":"7","key":"10.1016\/j.jbo.2025.100730_b0080","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2015-1259","article-title":"Effects of denosumab and calcitriol on severe secondary hyperparathyroidism in dialysis patients with low bone mass","volume":"100","author":"Chen","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.jbo.2025.100730_b0085","doi-asserted-by":"crossref","DOI":"10.1007\/s11657-023-01306-x","article-title":"Treatment of osteoporosis with denosumab in patients with decreased kidney function","volume":"18","author":"Svendsen","year":"2023","journal-title":"Arch. Osteoporos."},{"key":"10.1016\/j.jbo.2025.100730_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.semnephrol.2014.09.008","article-title":"Adynamic bone disease: From bone to vessels in chronic kidney disease","volume":"Vol. 34","author":"Bover","year":"2014","journal-title":"Semin. Nephrol."},{"issue":"2","key":"10.1016\/j.jbo.2025.100730_b0095","doi-asserted-by":"crossref","DOI":"10.1159\/000380960","article-title":"Hypocalcemia post denosumab in patients with chronic kidney disease stage 4-5","volume":"41","author":"Dave","year":"2015","journal-title":"Am. J. Nephrol."},{"issue":"6","key":"10.1016\/j.jbo.2025.100730_b0100","article-title":"Tolerability of denosumab in metastatic solid tumor patients with renal insufficiency","volume":"23","author":"Watkins","year":"2015","journal-title":"Support. Care Cancer"},{"issue":"2","key":"10.1016\/j.jbo.2025.100730_b0105","article-title":"Severe hypocalcemia after denosumab administration in a patient with chronic kidney disease: A case report","volume":"23","author":"Kouroglou","year":"2023","journal-title":"J. Musculos. Neuro. Interact."},{"issue":"12","key":"10.1016\/j.jbo.2025.100730_b0110","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.12022","article-title":"Mechanism of action and clinical outcomes","volume":"66","author":"Hanley","year":"2012","journal-title":"Int. J. Clin. Pract."},{"issue":"4","key":"10.1016\/j.jbo.2025.100730_b0115","article-title":"Risk factors for development of hypocalcemia in patients with cancer treated with bone-modifying agents","volume":"18","author":"White","year":"2020","journal-title":"JNCCN J. Nat. Comprehen. Cancer Network"},{"issue":"2","key":"10.1016\/j.jbo.2025.100730_b0120","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2016-3170","article-title":"Severe rebound-associated vertebral fractures after denosumab discontinuation: 9 clinical cases report","volume":"102","author":"Lamy","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbo.2025.100730_b0125","article-title":"Severe Hypocalcemia due to Denosumab in Metastatic Prostate Cancer","author":"Muqeet Adnan","year":"2014","journal-title":"Case Rep. Nephrol."}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137425000715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137425000715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T12:25:02Z","timestamp":1765023902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137425000715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":25,"alternative-id":["S2212137425000715"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2025.100730","relation":{},"ISSN":["2212-1374"],"issn-type":[{"type":"print","value":"2212-1374"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic kidney disease and denosumab in metastatic bone disease: A multicenter Turkish cohort study on severe hypocalcemia, skeletal events, and survival","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2025.100730","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100730"}}